SBP-9330

SBP 9330 is an investigational small-molecule drug and a positive allosteric modulator (PAM) of the metabotropic glutamate receptor 2 (mGluR2), being developed as a potential treatment for nicotine dependence and other substance-use…

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

SBP 9330 is an investigational small-molecule drug and a positive allosteric modulator (PAM) of the metabotropic glutamate receptor 2 (mGluR2), being developed as a potential treatment for nicotine dependence and other substance-use disorders.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374785084 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.